Soberana 02
Vaccine against COVID-19 / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Soberana COVID-19 vaccine?
Summarize this article for a 10 year old
Soberana 02 or Soberana 2, technical name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac (Persian: پاستوکووک) in Iran, where it has been developed in collaboration with the Pasteur Institute of Iran.[1][2][3]
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | Conjugate |
Clinical data | |
Trade names | Pasteur |
Other names | FINLAY-FR-2 Pasteurcovac, Pasto Covac, پاستوکووک |
Routes of administration | Intramuscular |
Legal status | |
Legal status |
|
Identifiers | |
DrugBank |
It is a conjugate vaccine that requires two doses, the second one being administered 28 days after the first shot.[4] A third (booster) dose of Soberana Plus may also be given on day 56. It has received emergency use authorization in Iran on June 2021, and in Cuba on August 2021, where it has also been approved for children above 2 years old.[5]
The name of the vaccine, Soberana, is a Spanish word that means "sovereign".[6] It followed a previous candidate vaccine called SOBERANA-01 (FINLAY-FR-1).[7]